Ye Yun-bin, Zhou Zhi-feng, Chen Qiang, Li Jie-yu, Chen Xia, Huang Wei-wei
Department of Immuno-Oncology, Fujian Provincial Tumor Hospital, the Teaching Hospital of Fujian Medical University, Fuzhou 350014, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Sep;24(9):904-7.
To determine the expression of soluble MICA (sMICA) in serum of patients with breast tumor, and explore the roles of sMICA in immune escape.
ELISA was used to examine the sMICA in peripheral blood. The expression of NKG2D were identified by Flow cytometry. The cytotoxicity of NK cells to breast cancer cells was observed with MTT assay.
sMICA was not detected in the serum of healthy person, but(76.8+/-22.3) ng/L in breast benign tumor patients and (205.4+/-71.3) ng/L in breast malignant tumor patients. There was positive correlation between sMICA levels and breast cancer stage. After incubation with sMICA, NK cells got decrease in cytotoxicity from (76.2+/-6.7) % to (48.4+/-4.1) % .The expression of NKG2D and secretion of IFN-gamma decreased at the same time. IL-15 up-regulated the expression of NKG2D on NK cells and increased NK cells cytotoxicity to breast cancer cells.
sMICA level is positive correlated with breast cancer TNM stage. sMICA reduced the expression of NKG2D, impaired NK-mediated immune surveillance and led to immune escape of breast tumor. IL-15 could up-regulate the expression of NKG2D and increase NK cells cytotoxicity.
检测乳腺癌患者血清中可溶性MICA(sMICA)的表达,探讨sMICA在免疫逃逸中的作用。
采用ELISA法检测外周血中sMICA水平。通过流式细胞术鉴定NKG2D的表达。采用MTT法观察NK细胞对乳腺癌细胞的细胞毒性。
健康人血清中未检测到sMICA,乳腺良性肿瘤患者血清中sMICA水平为(76.8±22.3)ng/L,乳腺恶性肿瘤患者血清中sMICA水平为(205.4±71.3)ng/L。sMICA水平与乳腺癌分期呈正相关。与sMICA孵育后,NK细胞的细胞毒性从(76.2±6.7)%降至(48.4±4.1)%,同时NKG2D的表达及IFN-γ的分泌减少。IL-15上调NK细胞上NKG2D的表达,并增加NK细胞对乳腺癌细胞的细胞毒性。
sMICA水平与乳腺癌TNM分期呈正相关。sMICA降低NKG2D的表达,损害NK细胞介导的免疫监视,导致乳腺肿瘤免疫逃逸。IL-15可上调NKG2D的表达并增加NK细胞的细胞毒性。